On Friday shares of NewStar Financial, Inc. (NASDAQ:NEWS) closed at $11.09. Company’s sales growth for last 5 years was 0.70% and EPS growth for next 5 years is recorded as 15.00%. On March 24, NewStar Financial Inc. (NASDAQ:NEWS) announced that it completed a $496 million term debt securitization known as NewStar Commercial Loan Funding 2015-1. All floating rate classes of notes were priced at par and the transaction size was increased from $400 million to $496 million to satisfy demand driven by broad participation among institutional investors.
Vascular Biogenics Ltd. (NASDAQ:VBLT) in last trading activity moved down -5.65% to close at $5.68. Company weekly performance is -1.22% while its quarterly performance stands at -5.33%. Vascular Biogenics Ltd. (NASDAQ:VBLT) is -66.63% away from its 52 week high. Vascular Biogenics Ltd. (NASDAQ:VBLT) announced Wednesday morning that its Phase 2 study of VB-111, in patients with recurrent glioblastoma, demonstrated a statistically significant improvement in overall survival in patients treated with VB-111 followed by VB-111 in combination with bevacizumab upon disease progression, compared to patients treated with VB-111 followed by bevacizumab alone upon disease progression.
On Friday shares of General Motors Company (NYSE:GM) closed at $37.31. Company’s sales growth for last 5 years was 8.30% and EPS growth for next 5 years is recorded as 17.86%. General Motors Company (NYSE:GM) will lean heavily on the 2016 Chevrolet Malibu to help boost its profits and grow its market share with plans to move more than 250,000 examples of the mid-size sedan a year, Reuters reports.
Centene Corp. (NYSE:CNC) has 5.20% insider ownership while its institutional ownership stands at 95.90%. In last trading activity company’s stock closed at $69.22. Centene Corp (NYSE:CNC) had its price objective raised by Barclays from $66.00 to $84.00 in a research report released on Friday morning. Barclays currently has an overweight rating on the stock.
On last trading day Quidel Corp. (NASDAQ:QDEL) advanced 2.38% to close at $27.15. Its volatility for the week is 3.81% while volatility for the month is 3.57%. QDEL’s sales growth for past 5 years was 2.10% and its EPS growth for past 5 years was -17.00%. Quidel Corp. (NASDAQ:QDEL) monthly performance is 4.38%. On March 19, Quidel Corp. (NASDAQ:QDEL) announced that it has received clearance from the United States Food and Drug Administration (FDA) to market its AmpliVue Trichomonas Assay for the detection of nucleic acids isolated from clinician-collected vaginal swab specimens obtained from symptomatic or asymptomatic female patients.